Skip to content
Hero image

Press room


Lyphe Group secures £5m in funding led by Leafy Tunnel

The UK-based medical cannabis ecosystem provider has received funding from Leafy Tunnel, a venture capital fund investing in European medical cannabis and global medical psychedelics companies. Sharp Capital Advisors, a leading US cannabis advisory firm also participated as an investor in the round. The funds are being used for expansion into multiple markets across Europe … Continued
Read

CEO Jonathan Nadler talks UK Medical Cannabis in The Daily Express

Recently, LYPHE Group CEO and Co-Founder Jonathan Nadler spoke to Christopher Sharp at the Daily Express on medical cannabis, the challenges the industry faces and what the next steps need to be.   “1.4 million people roughly are consuming illegally for medical reasons. There should be a lot more of those patients that have access … Continued
Read